I disagree. I get we are doing two simultaneous phase two trials now which is great but we were informed less than six months ago that recruitment for FSGS was going to commence in Q1 CY2018 with exploratory 2b read out in CY2018. Recruitment is now ‘expected’ to commence in Q3 CY2018 with preliminary data not ‘expected’ until Q3 CY2019. Now wonder Cathy has been shown the door…value is some way off yet and IMO a new CEO cannot come soon enough. Hopefully we get someone at the helm who can adhere to timelines and do more than one thing a time as the CR seems to have halted any actual progress beyond planning. Very disappointing. Looks like I will be wait another 12+ months for my 10 bags from this one.
Ann: Dual Phase 2 trials launched for CKD, page-3
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.035(6.67%) |
Mkt cap ! $310.8M | |||
| Open | High | Low | Value | Volume |
| 51.5¢ | 57.3¢ | 50.5¢ | $2.179M | 3.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30558 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |